Marinomed Biotech AG
VSE:MARI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Marinomed Biotech AG
VSE:MARI
|
AT |
|
Delta Resources Ltd
XTSX:DLTA
|
CA |
|
Alphatec Holdings Inc
NASDAQ:ATEC
|
US |
Wall Street
Price Targets
MARI Price Targets Summary
Marinomed Biotech AG
According to Wall Street analysts, the average 1-year price target for MARI is 52.02 EUR with a low forecast of 51.51 EUR and a high forecast of 53.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MARI's stock price target?
Price Target
52.02
EUR
According to Wall Street analysts, the average 1-year price target for MARI is 52.02 EUR with a low forecast of 51.51 EUR and a high forecast of 53.55 EUR.
What is Marinomed Biotech AG's Revenue forecast?
Projected CAGR
81%
For the last 7 years the compound annual growth rate for Marinomed Biotech AG's revenue is 0%. The projected CAGR for the next 4 years is 81%.
